Overview Drug Interaction Study of Digoxin and BI 10773 Status: Completed Trial end date: 1969-12-31 Target enrollment: Participant gender: Summary The objective of the study is to investigate the relative bioavailability of digoxin after concomitant multiple oral administration of BI 10773 and a single dose of digoxin in comparison to digoxin given alone to healthy male and female subjects. Phase: Phase 1 Details Lead Sponsor: Boehringer IngelheimTreatments: DigoxinEmpagliflozin